Sector revisions Divi's Laboratories Limited

Stocks

Delayed NSE India S.E. Other stock markets 04:35:08 10/07/2026 pm IST			5-day change	1st Jan Change
6,836.00 ^INR	+0.34%		+1.17%	+6.94%

26/05	Divi's Laboratories Limited announces Annual dividend, payable on September 09, 2026	CI
25/05	Choice Equity Upgrades Divi's Laboratories to Add from Reduce; Price Target is INR7,375	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DIVI'S LABORATORIES LIMITED							30
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	ASTRAZENECA PLC							22
	NOVARTIS AG							21
	NOVO NORDISK A/S							24
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							25
	BRISTOL-MYERS SQUIBB COMPANY							24
	GSK PLC							19
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	BAYER AG							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	ALNYLAM PHARMACEUTICALS, INC.							24
	Average							23
	Weighted average by Cap.							24